Hitting Previously Undruggable Targets with Oral Therapies episode artwork

EPISODE · Aug 27, 2025 · 27 MIN

Hitting Previously Undruggable Targets with Oral Therapies

from The Bio Report · host Levine Media Group

Macrocycles are complex compounds that can interact with targets that are often unreachable with traditional small molecules. Orbis Medicines is addressing the challenge with its nCycles, synthetic macrocycle drugs that are orally available but hit targets that would otherwise require biologic therapies. We spoke to Morten Graugaard, CEO of Orbis Medicines, about its class of synthetic macrocycles called nCycles, its platform technology to generate and screen these therapies, and how they can offer an orally-delivered alternative to biologics.

NOW PLAYING

Hitting Previously Undruggable Targets with Oral Therapies

0:00 27:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 27 minutes long.

When was this The Bio Report episode published?

This episode was published on August 27, 2025.

What is this episode about?

Macrocycles are complex compounds that can interact with targets that are often unreachable with traditional small molecules. Orbis Medicines is addressing the challenge with its nCycles, synthetic macrocycle drugs that are orally available but hit...

Can I download this The Bio Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!